Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anticancer Activity of Britannin Through the Downregulation of Cyclin D1 and Cdk4 in Human Breast Cancer Cells Publisher Pubmed



Hamzeloomoghadam M1, 2 ; Aghaei M3 ; Abdolmoham Madi M4 ; Fallahian F4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran

Source: Journal of Cancer Research and Therapeutics Published:2019


Abstract

Aim of the Study: Both apoptotic induction and cell cycle blockade in cancer cells are effective strategies to eliminate cancer cells. Many conventional cancer drugs that induce apoptosis and inhibit cell cycle progression have been reported as potential therapeutics for various types of cancer. Britannin is a natural sesquiterpene lactone that its profound anticancer properties were revealed in our previous study. In this study, we evaluated the effects of britannin on the cell cycle distribution and also cell cycle-related proteins. Materials and Methods: Analysis of cell cycle distribution was carried out using flow cytometer. The effects of britannin on cyclin D1 and CDK4 expression were evaluated using the Western blot. Results: The obtained results show that britannin at the low concentrations induces cell growth inhibition mainly through G1-phase arrest while it seems that apoptosis contributes to cell growth inhibitory effect of high doses of britannin. Reduction of cyclin D1 and CDK4 protein levels were also observed after treating cancer cells with britannin. Conclusion: The obtained results reveal that britannin can inhibit MCF-7 and MDA-MB-468 breast cancer cells proliferation through arresting cell cycle progression through cyclin D1/CDK4-mediated pathway. © 2018 Journal of Cancer Research and Therapeutics | Published by Wolters Kluwer - Medknow.
Experts (# of related papers)
Other Related Docs
14. Cytotoxicity Effect of Pineapple Extract on Breast Cancer Cells (4T1), Journal of Isfahan Medical School (2016)
30. Role of Cyclin D1 in Breast Carcinoma, Journal of Research in Medical Sciences (2013)